v3.26.3
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Net loss $ (15,140) $ (9,678)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation of property and equipment 55 37
Interest income and unrealized gains from marketable securities (204) (282)
Share-based compensation 1,017 821
Changes in assets and liabilities:    
Accounts receivable (90)
Inventory (2,629)
Prepaid expenses and other assets 130 (175)
Other payables and accrued liabilities 1,412 (11)
Net cash flows used in operating activities (15,449) (9,288)
Investing activities:    
Purchases of property and equipment (365) (35)
Purchases of marketable securities (1,652) (79,918)
Proceeds from sales of marketable securities 17,000 9,102
Increase in long-term deposit (148)
Increase in restricted deposit (821)
Net cash flows provided by (used in) investing activities 14,014 (70,851)
Financing activities:    
Issuance of common stock and warrants, net 16 83,733
Exercise of options 1
Net cash flows provided by financing activities 16 83,734
(Decrease) increase in cash, cash equivalents and restricted cash (1,419) 3,595
Cash, cash equivalents and restricted cash at beginning of period 3,973 3,163
Cash, cash equivalents and restricted cash at end of period 2,554 6,758
Supplemental disclosure of non-cash investing and financing activities:    
Right-of-use assets obtained in exchange for lease liabilities 164 893
Issuance costs not paid 153
Deferred issuance costs 30
Purchase of property and equipment 83
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 2,292 6,704
Restricted cash 262 54
Cash, cash equivalents and restricted cash $ 2,554 $ 6,758